$58.85
0.06[0.10%]
At close: Apr 26
$58.85
0[0.00%]
After Hours: 4:00PM EDT
Exact Sciences: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Apr 03, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -2K | $70.00 | -$140.00K | SELL | -2.52% | 77.513K | Apr 01 | View |
Apr 03, 2024 | Brian Baranick | EVP, GM., PRECISION ONCOLOGY | -924 | $79.43 | -$73.39K | SELL | -6.35% | 13.625K | Apr 02 | View |
Apr 01, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | -2K | $70.00 | -$140.00K | SELL | -2.45% | 79.513K | Mar 28 | View |
Mar 04, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 2.57K | $59.32 | -$127.78K | SELL-OPTIONS | 19.97% | 15.441K | Feb 29 - Mar 01 | View |
Mar 04, 2024 | Daniel J Levangie | DIRECTOR | -5K | $57.50 | -$287.50K | SELL | -17.87% | 22.975K | Mar 01 | View |
Mar 04, 2024 | James Herriott | GENERAL COUNSEL | 1.028K | $59.32 | -$51.13K | SELL-OPTIONS | 11.08% | 10.308K | Feb 29 - Mar 01 | View |
Mar 04, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.879K | $59.32 | -$143.08K | SELL-OPTIONS | 29.87% | 12.518K | Feb 29 - Mar 01 | View |
Mar 04, 2024 | James Edward Doyle | DIRECTOR | -2K | $57.50 | -$115.00K | SELL | -3.84% | 50.11K | Mar 01 | View |
Mar 04, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 2.879K | $59.32 | -$143.08K | SELL-OPTIONS | 6.56% | 46.75K | Feb 29 - Mar 01 | View |
Mar 04, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 9.872K | $59.32 | -$490.64K | SELL-OPTIONS | 0.75% | 1.321225M | Feb 29 - Mar 01 | View |
Mar 04, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 2.055K | $59.32 | -$102.27K | SELL-OPTIONS | 2.59% | 81.513K | Feb 29 - Mar 01 | View |
Mar 04, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 2.401K | $59.32 | -$137.80K | SELL-OPTIONS | 19.76% | 14.549K | Feb 29 - Mar 01 | View |
Feb 28, 2024 | Jacob A Orville | GENERAL MANAGER, SCREENING | 2.075K | $56.89 | -$106.90K | SELL-OPTIONS | 19.22% | 12.871K | Feb 26 - Feb 27 | View |
Feb 28, 2024 | James Herriott | GENERAL COUNSEL | 864 | $56.89 | -$44.60K | SELL-OPTIONS | 10.27% | 9.28K | Feb 26 - Feb 27 | View |
Feb 28, 2024 | Everett Cunningham | CHIEF COMMERCIAL OFFICER | 4.03K | $56.89 | -$207.53K | SELL-OPTIONS | 10.12% | 43.871K | Feb 26 - Feb 27 | View |
Feb 28, 2024 | Jeffrey T. Elliott | CHIEF FINANCIAL OFFICER | 2.991K | $56.89 | -$154.17K | SELL-OPTIONS | 44.99% | 9.639K | Feb 26 - Feb 27 | View |
Feb 28, 2024 | Kevin T Conroy | PRESIDENT AND CEO | 6.918K | $56.89 | -$356.30K | SELL-OPTIONS | 0.53% | 1.311353M | Feb 26 - Feb 27 | View |
Feb 28, 2024 | Sarah Condella | EVP, HUMAN RESOURCES | 2.074K | $56.89 | -$106.95K | SELL-OPTIONS | 2.68% | 79.458K | Feb 26 - Feb 27 | View |
Feb 28, 2024 | Brian Baranick | GEN. MGR., PRECISION ONCOLOGY | 1.927K | $56.89 | -$115.32K | SELL-OPTIONS | 18.85% | 12.148K | Feb 26 - Feb 27 | View |
Browse insider trades on all stocks.